Medicinova Inc SEC filings MNOV

Medicinova Inc has 879 filings in SEC EDGAR's recent list, going back to Apr 8, 2003. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 28, 2026 (material agreement). The company's fiscal year ends on December 31.

Medicinova Inc SEC filings
Form Description Filed Period
424B5 Prospectus supplement Dec 30, 2025 —
S-3 Shelf registration Dec 5, 2025 —
S-1 Registration statement Aug 22, 2025 —
S-8 POS Filing Jan 19, 2024 —
S-8 POS Filing Jan 19, 2024 —
S-8 POS Filing Jan 19, 2024 —
S-8 POS Filing Jan 19, 2024 —
424B5 Prospectus supplement Sep 30, 2022 —
S-3 Shelf registration Aug 26, 2022 —
S-8 Employee stock plan registration May 13, 2022 —
424B3 Prospectus Feb 12, 2021 —
S-3 Shelf registration Jan 29, 2021 —
424B5 Prospectus supplement Aug 23, 2019 —
S-3 Shelf registration Aug 9, 2019 —
S-8 Employee stock plan registration Jun 21, 2019 —
424B5 Prospectus supplement Feb 8, 2018 —
424B5 Prospectus supplement Feb 7, 2018 —
S-3 Shelf registration Sep 22, 2017 —
S-8 Employee stock plan registration Jul 26, 2017 —
424B3 Prospectus Dec 9, 2016 —
S-3 Shelf registration Nov 29, 2016 —
424B5 Prospectus supplement Sep 16, 2016 —
S-3/A Filing Aug 24, 2016 —
S-3/A Filing Dec 18, 2015 —
S-3 Shelf registration Dec 1, 2015 —
424B5 Prospectus supplement Aug 19, 2015 —
424B3 Prospectus Aug 18, 2015 —
424B5 Prospectus supplement May 22, 2015 —
424B5 Prospectus supplement Oct 16, 2013 —
S-8 Employee stock plan registration Aug 8, 2013 —
424B5 Prospectus supplement Apr 18, 2013 —
S-3 Shelf registration Nov 16, 2012 —
424B5 Prospectus supplement Aug 21, 2012 —
424B5 Prospectus supplement May 6, 2011 —
424B5 Prospectus supplement Mar 24, 2011 —
424B5 Prospectus supplement Mar 23, 2011 —
S-3/A Amendment no. 1 to form s-3 Dec 10, 2009 —
S-4/A Amendment no. 3 to form s-4 Nov 18, 2009 —
S-4/A Amendment no. 2 to form s-4 Nov 16, 2009 —
S-3 Shelf registration Nov 13, 2009 —
S-4/A Amendment no. 1 to form s-4 Oct 23, 2009 —
S-4 Registration for a merger or exchange Sep 17, 2009 —
S-8 Employee stock plan registration Jun 20, 2008 —
424B5 Prospectus supplement Oct 25, 2007 —
S-8 Employee stock plan registration Mar 30, 2007 —
424B5 Prospectus supplement Jan 30, 2007 —
424B3 Prospectus Jan 24, 2007 —
424B3 Prospectus Jan 3, 2007 —
S-3/A Amendment no. 1 to form s-3 Nov 14, 2006 —
S-3 Shelf registration Oct 27, 2006 —
POS AM Post-effective amendment Feb 16, 2006 —
424B1 Form 424(b)(1) Dec 9, 2005 —
S-1 Registration statement Nov 23, 2005 —
424B3 Prospectus Nov 15, 2005 —
S-1/A Amended registration statement Sep 19, 2005 —
S-1 Registration statement Sep 1, 2005 —
424B3 Prospectus Mar 22, 2005 —
S-8 Employee stock plan registration Feb 9, 2005 —
424B1 424 final prospectus Jan 31, 2005 —
S-1/A Amended registration statement Jan 27, 2005 —
S-1/A Amended registration statement Jan 25, 2005 —
S-1/A Amended registration statement Jan 6, 2005 —
S-1/A Amended registration statement Nov 24, 2004 —
S-1 Registration statement Oct 1, 2004 —

Showing 64 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
MNOV (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
La Jolla, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1226616

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.